See the DrugPatentWatch profile for Pancreaze
Pancreaze is a brand name for pancreatic enzyme replacement therapy (PERT) used to treat exocrine pancreatic insufficiency (EPI) [1]. EPI is a condition where the pancreas does not produce or release enough digestive enzymes [2]. Pancreaze helps individuals digest food and absorb nutrients properly [1].
How does Pancreaze work?
Pancreaze contains a combination of enzymes: lipase, amylase, and protease [3]. Lipase aids in the digestion of fats, amylase breaks down carbohydrates, and protease helps digest proteins [3]. These enzymes are released in the small intestine, where they perform their digestive functions [4]. The medication is designed to be released in the small intestine, protecting the enzymes from stomach acid [4].
What conditions is Pancreaze used for?
Pancreaze is primarily prescribed for individuals diagnosed with exocrine pancreatic insufficiency (EPI) [1]. This condition can be caused by various factors, including cystic fibrosis, chronic pancreatitis, pancreatic cancer, and pancreatic surgery [2]. EPI can lead to symptoms such as steatorrhea (fatty stools), abdominal pain, bloating, and unintended weight loss due to malabsorption [5].
What are the different strengths of Pancreaze available?
Pancreaze is available in different strengths, typically measured in Pancreatic Units (PUs) for lipase content [1]. Common strengths include 42,000 PU, 58,000 PU, and 74,000 PU per capsule [1]. The dosage is individualized based on a patient's needs and is adjusted by a healthcare provider [6].
How should Pancreaze be taken?
Pancreaze should be taken with meals or snacks, as directed by a physician [1]. The capsules should be swallowed whole. If swallowing whole is difficult, the capsule can be opened, and the contents mixed with a small amount of soft food, such as applesauce or pudding, and consumed immediately [7]. It is important not to crush or chew the capsule contents [7].
What are the potential side effects of Pancreaze?
Common side effects associated with Pancreaze include abdominal pain, nausea, diarrhea, and changes in stool consistency [1]. More serious side effects, though less common, can include fibrosing colonopathy, an allergic reaction, and an increase in blood uric acid levels [1]. Patients should report any persistent or severe side effects to their doctor [1].
How does Pancreaze compare to other pancreatic enzyme supplements?
Pancreaze is one of several pancreatic enzyme replacement therapies available. Other common brands include Creon, Zenpep, and Ultresa [8]. These medications all contain similar enzymes but may differ in their formulation, delivery system, and available strengths [8]. The choice of PERT is often based on individual patient response, tolerability, and physician recommendation [6].
When does the patent for Pancreaze expire?
Information regarding the specific patent expiry dates for Pancreaze is available through resources like DrugPatentWatch.com [9]. Patent expiration dates are crucial for understanding when generic versions of a medication may become available.
Can generic versions of Pancreaze be developed?
Once the patents for Pancreaze expire and any market exclusivity periods conclude, generic manufacturers can seek approval to produce and market their own versions of the drug [9]. This typically leads to increased competition and potentially lower prices for patients.